Allergan Breast Implant Lawsuit | Textured Implants Linked to Rare Form of Cancer
About the Allegran Textured Breast Implant Recall:
In July of 2019, the FDA requested that the pharmaceutical company, Allergan, recall all BioCell textured breast implants and tissue expanders due to a significantly increased risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
According to the FDA, continued distribution of Allergan’s BioCell textured breast implants would likely cause serious adverse health consequences and potentially death from BIA-ALCL, and that these implants carry with them approximately 6 times the risk of contracting BIA-ALCL than with textured implants from other manufacturers. 
About Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
Breast Implant-Associated Anaplastic Large Cell Lymphoma is not breast cancer; it is a cancer of the immune system and is a type of non-Hodgkin’s lymphoma. Lymphoma cells form in fluids surrounding the breast implant and in the scar tissue.